mgwas
-
Exploring a genetic basis for the metabolic perturbations in ME/CFS using UK Biobank, 2025, Armstrong et al
Abstract: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a clinically heterogeneous disease lacking approved therapies. To assess genetic susceptibility towards a specific metabolic phenotype, we performed a genome-wide association study on plasma biomarker levels (mGWAS) in...- Nightsong
- Thread
- chris armstrong mgwas phospholipids snp
- Replies: 6
- Forum: ME/CFS research news